2-Hydroxy-N-1H-1,2,4-triazol-3-ylbenzamide

Suppliers

Names

[ CAS No. ]:
36411-52-6

[ Name ]:
2-Hydroxy-N-1H-1,2,4-triazol-3-ylbenzamide

[Synonym ]:
EINECS 253-021-4
2-hydroxy-N-1H-1,2,4-triazol-3-ylbenzamide
3-Salicylamido-1H-1,2,4-triazole
Benzamide,2-hydroxy-N-1H-1,2,4-triazol-3-yl
MARK 1475
Salicyloylaminotriazole

Chemical & Physical Properties

[ Density]:
1.552

[ Melting Point ]:
275-276ºC

[ Molecular Formula ]:
C9H8N4O2

[ Molecular Weight ]:
204.18500

[ Exact Mass ]:
204.06500

[ PSA ]:
90.90000

[ LogP ]:
0.83560

[ Index of Refraction ]:
1.745

[ Storage condition ]:
-20°C

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
VN7842000
CHEMICAL NAME :
Salicylamide, N-(2H-1,2,4-triazol-5-yl)-
CAS REGISTRY NUMBER :
36411-52-6
LAST UPDATED :
199701
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C9-H8-N4-O2
MOLECULAR WEIGHT :
204.21
WISWESSER LINE NOTATION :
T5MN DNJ CMVR BQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value

MUTATION DATA

TYPE OF TEST :
Morphological transformation
TEST SYSTEM :
Rodent - hamster Embryo
DOSE/DURATION :
10 mg/L
REFERENCE :
TOLED5 Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- Volume(issue)/page/year: 7,211,1981

Safety Information

[ HS Code ]:
2933990090

Synthetic Route

Precursor & DownStream

Precursor

  • Amitrole
  • Phenyl salicylate

DownStream

Customs

[ HS Code ]: 2933990090

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%


Related Compounds

  • 4-nitro-N-(1H-1,2,4-triazol-5-yl)benzamide
  • 2-(5-Hydroxy-1H-[1,2,4]triazol-3-ylamino)-4-methyl-thiazole-5-carboxylic acid ethyl ester
  • 2-Naphthalenecarboxamide,3-hydroxy-N-1H-1,2,4-triazol-5-yl-
  • 2-Furancarboxamide,5-(methylamino)-N-1H-1,2,4-triazol-3-yl- (9CI)
  • 2-(1H-1,2,4-Triazol-3-yl)pyridine
  • 3-Pyridinemethanamine,N-1H-1,2,4-triazol-3-yl-(9CI)
  • n-(5-Nitroimidazo[2,1-b]thiazol-6-yl)morpholin-4-amine
  • (E)-2-(5-((5-(4-methyl-2-nitrophenyl)furan-2-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)-4-(methylthio)butanoic acid
  • Glycine, N-valyl-, benzyl ester
  • N-(pyridin-3-ylmethyl)tetrazolo[1,5-b]pyridazin-6-amine
  • 4-Amino-n-(5-methyl-thiazol-2-yl)-benzamide
  • N-(1-adamantylmethyl)-2-[methyl-[(E)-2-phenylethenyl]sulfonylamino]acetamide
  • 3-Bromo-4-methoxy-N-(5-methylisoxazol-3-yl)benzamide
  • 2-Methoxy-2-(4-methylphenyl)acetic acid
  • N-[2-(2-chlorophenyl)-1,3-benzoxazol-5-yl]-2-methyl-propanamide
  • 3-[4,6-dimethyl-2-(methylsulfanyl)pyrimidin-5-yl]-N-(quinolin-8-yl)propanamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.